5-Bromo-2-fluoronicotinaldehyde

Catalog No.: 
ACSMTE960
CAS No.: 
875781-15-0
Molecular Formula: 
C6H3BrFNO
Molecular Weight: 
204.00
5-Bromo-2-fluoronicotinaldehyde structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100g98%$152.00In stockInquiry
500g98%$756.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Bromo-2-fluoronicotinaldehyde
IUPAC Name5-bromo-2-fluoronicotinaldehyde
MDL No.MFCD09842440
Molecular FormulaC6H3BrFNO
Molecular Weight204.00
SMILESBrC1=CN=C(C(=C1)C=O)F
InChI KeyMUYVOGAJRCBWCY-UHFFFAOYSA-N
Synonym875781-15-0 | 5-bromo-2-fluoronicotinaldehyde | 5-BROMO-2-FLUOROPYRIDINE-3-CARBOXALDEHYDE | 5-bromo-2-fluoropyridine-3-carbaldehyde | 5-Bromo-2-fluoro-3-pyridinecarboxaldehyde | 5-Bromo-2-fluoro-pyridine-3-carbaldehyde | MFCD09842440 | 5-Bromo-2-fluoro-3-formylpyridine
CAS No.875781-15-0
PubChem CID45480192

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H332-H335
Precautionary Statement(s)
P261-P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACSMTE960 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACIWBF532 route compound structure diagram
    ACIWBF532766-11-0In Stock
  2. Then
  3. ACSMTE960 route product structure diagram
    ACSMTE960875781-15-0In Stock
Inquiry

2. ACSMTE960 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACIWBF532 route compound structure diagram
    ACIWBF532766-11-0In Stock
  4. Then
  5. ACSMTE960 route product structure diagram
    ACSMTE960875781-15-0In Stock
Inquiry

3. ACSMTE960 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACSMTE960 route product structure diagram
    ACSMTE960875781-15-0In Stock
Inquiry

Comments (0)